Stansberry Asset Management’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-103,921
Closed -$372K 101
2022
Q4
$372K Buy
103,921
+2,391
+2% +$10.2K 0.08% 93
2022
Q3
$410K Sell
101,530
-2,334
-2% -$12K 0.09% 90
2022
Q2
$463K Sell
103,864
-70,659
-40% -$510K 0.1% 93
2022
Q1
$1.48M Buy
174,523
+12,058
+7% +$84.7K 0.24% 62
2021
Q4
$1.44M Buy
+162,465
New +$1.54M 0.23% 55

Other funds holding SRTA

Stansberry Asset Management's SRTA Position: Q1 2023 in Review

Stansberry Asset Management sold out of Strata Critical Medical Inc (SRTA) in Q1 2023, closing a stake of 103,921 shares — an estimated $372K sold.

Stansberry Asset Management first reported a position in SRTA in Q4 2021 and held it in 5 quarters. The position peaked at $1.48M in Q1 2022. 93 funds tracked by Wall St. Rank hold SRTA as of Q1 2023.

  • Stansberry Asset Management reported no remaining Strata Critical Medical Inc position as of Q1 2023 after selling out during the quarter.
  • Stansberry Asset Management sold 103,921 Strata Critical Medical Inc shares in Q1 2023, an estimated $372K.
  • Stansberry Asset Management first reported a position in Strata Critical Medical Inc in Q4 2021 and held it in 5 quarters.
  • Stansberry Asset Management's Strata Critical Medical Inc position peaked at $1.48M in Q1 2022.
  • 93 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2023.

Based on Stansberry Asset Management's 13F filing for Q1 2023, filed 12 May 2023.